Elizaveta Ivanovna Basanova

Elizaveta Ivanovna Basanova

Auto-generated profile, based on publicly available information

Elizaveta Ivanovna Basanova

D.I. Mendeleyev University of Chemical Technology of Russia, Moscow, Russia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2024 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
EBElizaveta I. Basanova
Elizaveta I. Basanova
EKEkaterina A. Kulikova
Ekaterina A. Kulikova
NBNikolai I. Bormotov
Nikolai I. Bormotov
OSOlga A. Serova
Olga A. Serova
LSLarisa N. Shishkina
Larisa N. Shishkina
PNPolina A. Nikitina
Polina A. Nikitina
Scientific interest in orthopoxvirus infections and search for new highly effective compounds possessing antiviral activity against orthopoxviruses have significantly increased as a result of worldwide mpox outbreak in 2022. The present work deals with the synthesis of new 2-arylimidazoles exhibiting in vitro activity not only against the vaccinia virus, cowpox virus and ectromelia (mousepox) virus but also against the variola virus. Among the imidazole derivatives under consideration (1-hydroxyimidazoles, 1-methoxyimidazoles, 1-benzyloxyimidazoles, and imidazole N-oxides), the most promising antiviral activity is demonstrated by 1-hydroxyimidazoles, which may exist as two prototropic tautomers. Both of these tautomers may be manifested in different crystal structures of these compounds, according to single-crystal X-ray diffraction analysis, while predominantly one of them (N-hydroxy-tautomeric form) is present in DMSO-d6 solutions and in the gaseous state, as shown by NMR spectroscopy and quantum-chemical calculations. The leader compound 1-hydroxy-2-(4-nitrophenyl)imidazole 4a demonstrated the highest selectivity indices against the vaccinia virus (SI = 1072) and the variola virus (SI = 373).

20 October 2025 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
VGVladislav O. Golfarb-Abramov
Vladislav O. Golfarb-Abramov
AKAnastasia V. Kazennova
Anastasia V. Kazennova
EBElizaveta Ivanovna Basanova
Elizaveta Ivanovna Basanova
OSOlga A. Serova
Olga A. Serova
NBNikolai I. Bormotov
Nikolai I. Bormotov
PNPolina A. Nikitina
Polina A. Nikitina
Structural features (isomers, tautomers, conformers) of N -substituted 2-(2-arylethenyl)imidazoles were considered. Antiviral activity against orthopoxviruses was evaluated, with 1-methoxyimidazoles being the most promising compounds.

1 December 2025 in Russian Journal of General Chemistry
Verified
Journal Article
Closed access
PDF file
EBElizaveta I. Basanova
Elizaveta I. Basanova
DZDenis A. Zhuravlev
Denis A. Zhuravlev
VGVladislav O. Golfarb-Abramov
Vladislav O. Golfarb-Abramov
TKTatyana Yu. Koldaeva
Tatyana Yu. Koldaeva
OYOl’GA I. Yarovaya
Ol’GA I. Yarovaya
PNPolina A. Nikitina
Polina A. Nikitina
The reduction of 1-hydroxydimiazole derivatives containing a nitrophenyl substituent was studied. Reduction of either 1-hydroxy-4,5-dimethyl-2-(4-nitrophenyl)imidazole or 1-hydroxy-4,5-dimethyl-2-[2-(4-nitrophenyl)ethenyl]imidazole with sodium dithionite promptly resulted in products of complete reduction, i.e., aniline-containing imidazoles with no additional substituents at the nitrogen atoms in positions 1 and 3 of the heterocycle. Two synthetic routes to 5-acetylimidazoles containing 2-(4-aminophenyl) or 2-[2-(4-aminophenyl)ethenyl] moieties with no substituents at the nitrogen atoms of the heterocycle were proposed. These compounds were obtained as by-products in the reduction reactions of starting 5-acetyl-1-hydroxyimidazole derivatives with either sodium dithionite in the presence of base in THF–H2O media or zinc in glacial acetic acid. Otherwise, these aminophenyl-containing 5-acetylimidazoles were synthesized by a two-step procedure including selective reduction of the hydroxyl group in position 1 of nitrophenyl-substituted imidazoles followed by the reduction of the nitro group of the substituent with sodium dithionite. The possibility of the acquisition of 5-acetyl-1-hydroxyimidazole derivatives containing a primary amino group in the aryl substituent was also demonstrated for the first time.

1 February 2025 in Russian Journal of General Chemistry
Verified
Journal Article
Closed access
PDF file
EBE. I. Basanova
E. I. Basanova
TKT. Yu. Koldaeva
T. Yu. Koldaeva
VPV. P. Perevalov
V. P. Perevalov
PNPolina A. Nikitina
Polina A. Nikitina
The predominant tautomer form of 5-ethoxycarbonyl-substituted 1-hydroxyimidazoles (exhibiting antiviral activity towards orthopoxviruses) in a solution of aprotic DMSO-d6 has been elucidated from the data of 1Н and 13С NMR spectroscopy in comparison with model structures. The IR spectra (KBr pellets) have been considered. It has been shown that 1-hydroxyimidazoles 3а, 3b predominantly exist as N-hydroxy tautomers in the solution, forming crystal hydrates in the solid state, in which water favors the shift of the tautomeric equilibrium towards the N-oxide.

1 November 2025 in Russian Journal of General Chemistry
Verified
Journal Article
Closed access
PDF file
EBElizaveta I. Basanova
Elizaveta I. Basanova
EKEkaterina M. Kulinich
Ekaterina M. Kulinich
IMIvan A. Moskalev
Ivan A. Moskalev
AFAlexey Yu. Fedorov
Alexey Yu. Fedorov
SASergey G. Arkhipov
Sergey G. Arkhipov
PNPolina A. Nikitina
Polina A. Nikitina
Hybrid chalcones containing 1-hydroxyimidazole and chromene moieties were synthesized from 5-acetyl-1-hydroxyimidazoles and 3-formylchromenes. Application of DBU as a catalyst led to the mixtures of the target chalсones and intermediate aldols. Further interaction of the mixtures with 40% aqueous solution of sodium hydroxide in ethanol resulted in pure chalсones, isolated as trans-isomers. According to X-ray single crystal diffraction analysis, (E)-3-{3-[2-(4-fluorophenyl)-1-hydroxy-4-methyl-1H-imidazol-5-yl]-3-oxoprop-1-en-1-yl}-6-methyl-4H-chromen-4-one exists as an N-hydroxyimidazole tautomer. Its planar structure is stabilized by the intramolecular hydrogen bond between the N-hydroxy group of the imidazole and the adjacent carbonyl group. The (E)-3-{3-[2-(4-fluorophenyl)-1-hydroxy-4-methyl-1H-imidazol-5-yl]-3-oxoprop-1-en-1-yl}-6-methyl-4H-chromen-4-one molecules in crystal were head-to-tail packed.